Physician profile
Benjamin D Levine
NPI 1508985565
$58,616.70
in general payments reported to CMS, 2019-2025
6 companies · $2,530 in 2025
The $2,530 reported for 2025 was more than what 92% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,248 · 2020: $2,500 · 2021: $9,500 · 2022: $8,379 · 2023: $18K · 2024: $14K · 2025: $2,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $4,041 · Honoraria: $2,500 · Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,450.00 |
| Travel and Lodging | $4,041.11 |
| Honoraria | $2,500.00 |
| Food and Beverage | $999.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $39,184.86 | 2022-2024 | Trek |
| Canon Medical Systems USA, INC. | $18,867.62 | 2019-2025 | Diagnostic Ultrasound System, General Device(S) |
| Becton, Dickinson and Company | $265.62 | 2023 | |
| Siemens Medical Solutions USA, INC. | $184.65 | 2019 | |
| Nalu Medical, INC. | $60.69 | 2022-2024 | Nalu Neurostimulation System |
| Novartis Pharmaceuticals Corporation | $53.26 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.